LABS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.45%

Insider Buying (Last 12 Months): C$0.00

Insider Selling (Last 12 Months): C$14,142.88

MediPharm Labs Insider Trading History Chart

MediPharm Labs Share Price & Price History

C^$0.08

▲ +0.005 (7.14%)

As of 06/12/2026 03:33 PM ET

Days: 30 | 90 | 365

MediPharm Labs Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/9/2026	Christopher David Taves	Director	Sell	176,786	C$0.08	C$14,142.88	2,847,939

SEC Filings (Institutional Ownership Changes) for MediPharm Labs (TSE:LABS)

0.34% of MediPharm Labs stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.

Today's Range

Now: C$0.08

C$0.07

C$0.08

50 Day Range

MA: C$0.07

C$0.06

C$0.09

52 Week Range

Now: C$0.08

C$0.06

C$0.10

Volume

76,864 shs

Average Volume

237,701 shs

Market Capitalization

C$31.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MediPharm Labs?: MediPharm Labs' top insider shareholders include:
Patrick Mccutcheon (Director)
Christopher David Taves (Director)
Learn More about top insider investors at MediPharm Labs.